Sign inJoin waitlistJoin the waitlist

MF

Mark Faber

Physician · Banner Gateway Medical Center

Credentials: · · ·

History

Banner Gateway Medical Center
2023–Present

Hematology and Medical Oncology
University at Buffalo School of Medicine
2020–2023
Internal Medicine
University at Buffalo School of Medicine
2017–2020
Lake Erie Coll of Osteo Med
2013–2017

Research

Mutant PPM1D- and TP53-Driven Hematopoiesis Populates the Hematopoietic Compartment in Response to Peptide Receptor Radionuclide Therapy
JCO Precision Oncology · 2022 · 45 citations
Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy
Blood Advances · 2022 · 19 citations
Predictors of vascular disease in myelodysplastic syndromes
eJHaem · 2020 · First of 8 authors · Corresponding · 6 citations

Elizabeth Griffiths
7 papers
Eunice Wang
7 papers
Amanda Przespolewski
5 papers
Abhay Singh
4 papers · 4 as a fellow
James Thompson
4 papers
Swapna Thota
4 papers
Grace Dy
2 papers
Hongbin Chen
2 papers
MG
Matthew Gravina
2 papers · 1 as a resident
PS
Pamela Sung
2 papers
Steven Green
2 papers
Alaa Altahan
1 paper

Clinical trials

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Site PI · Recruiting · Phase 3
Takeda
2026–2034
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Site PI · Recruiting · Phase 3
Takeda
2026–2033
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Site PI · Recruiting · Phase 1, Phase 2
Disc Medicine, Inc
2022–2027